Literature DB >> 18515052

Survivorship, late effects and cancer of the cervix.

E J Maher1, A Denton.   

Abstract

As the prevention and treatment of cervical cancer improves, there is increasing focus on the months and years after cancer treatment. Of those women living after a diagnosis of cancer, 10% will have a gynaecological malignancy and although the incidence of cervix cancer has dropped over the last 20 years, so has the age at diagnosis, with more than 60% surviving at least 5 years. In a recent report, 63% of 231 064 US survivors of cervix cancer were more than 10 years from diagnosis. More survivors are living long enough to develop chronic treatment-related conditions. The 2007 English Cancer Reform Strategy highlighted the importance of cancer survivorship and uses the US National Coalition for Cancer Survivorship definition-'living through and beyond cancer'. The emerging picture is of populations living after a diagnosis of cancer without active disease, still having similar health and disability profiles to populations with a diagnosis of a chronic illness. This offers new challenges in identifying and meeting their needs.

Entities:  

Mesh:

Year:  2008        PMID: 18515052     DOI: 10.1016/j.clon.2008.04.009

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  11 in total

1.  Patient preferences for side effects associated with cervical cancer treatment.

Authors:  Charlotte Sun; Alaina J Brown; Anuja Jhingran; Michael Frumovitz; Lois Ramondetta; Diane C Bodurka
Journal:  Int J Gynecol Cancer       Date:  2014-07       Impact factor: 3.437

2.  Bladder and bowel symptoms in cervical and endometrial cancer survivors.

Authors:  Kristine A Donovan; Alice R Boyington; Patricia L Judson; Jean F Wyman
Journal:  Psychooncology       Date:  2014-01-30       Impact factor: 3.894

3.  A study to evaluate the cause of bone demineralization in gynecological cancer survivors.

Authors:  Chara Stavraka; Kate Maclaran; Hani Gabra; Roshan Agarwal; Sadaf Ghaem-Maghami; Alexandra Taylor; Waljit S Dhillo; Nick Panay; Sarah P Blagden
Journal:  Oncologist       Date:  2013-01-30

4.  Risk of colorectal cancer among long-term cervical cancer survivors.

Authors:  Ana M Rodriguez; Yong-Fang Kuo; James S Goodwin
Journal:  Med Oncol       Date:  2014-04-03       Impact factor: 3.064

5.  Assessment of treatment-induced female sexual morbidity in oncology: is this a part of routine medical follow-up after radical pelvic radiotherapy?

Authors:  I D White; H Allan; S Faithfull
Journal:  Br J Cancer       Date:  2011-09-06       Impact factor: 7.640

6.  Anti Proliferative and Apoptotic Effect of Soluble Ethyl Acetate Partition from Ethanol Extract of Chromolaena Odorata Linn Leaves Against Hela Cervical Cancer Cell line.

Authors:  Hanifah Yusuf; Marhami Fahriani; Cut Murzalina
Journal:  Asian Pac J Cancer Prev       Date:  2022-01-01

Review 7.  Measuring health-related quality of life in cervical cancer patients: a systematic review of the most used questionnaires and their validity.

Authors:  Casper Tax; Marlie E Steenbergen; Petra L M Zusterzeel; Ruud L M Bekkers; Maroeska M Rovers
Journal:  BMC Med Res Methodol       Date:  2017-01-26       Impact factor: 4.615

8.  Impact of Ospemifene on Quality of Life and Sexual Function in Young Survivors of Cervical Cancer: A Prospective Study.

Authors:  Nicoletta De Rosa; Giada Lavitola; Pierluigi Giampaolino; Ilaria Morra; Carmine Nappi; Giuseppe Bifulco
Journal:  Biomed Res Int       Date:  2017-07-11       Impact factor: 3.411

Review 9.  Sexual Dysfunction in Cervical Cancer Survivors: A Scoping Review.

Authors:  Neha Mishra; Nilanchali Singh; Mohini Sachdeva; Prafull Ghatage
Journal:  Womens Health Rep (New Rochelle)       Date:  2021-12-07

10.  The impact of radiotherapy late effects on quality of life in gynaecological cancer patients.

Authors:  C L Barker; J A Routledge; D J J Farnell; R Swindell; S E Davidson
Journal:  Br J Cancer       Date:  2009-04-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.